Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
A batch of generics for Eli Lilly’s cancer drug Alimta (pemetrexed) have received approval for a new dosage regimen to allow their use for a combination therapy with MSD’s anti-PD-1 antibody Keytruda (pembrolizumab). Last year, Keytruda had added an additional…
To read the full story
Related Article
- Japan Approves Label Expansions for Alecensa, Nucala and More
August 29, 2024
BUSINESS
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026
- Toho, SDF Hospital Conduct Emergency Drug Supply Drill
November 19, 2026
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026





